Knowledge and acceptability of the Lémann Index as a tool to measure disease progression and bowel damage in Crohn’s disease: results from an international survey
Year: 2025
Type: article
Study design: Observational Study
Abstract: BACKGROUND/AIMS: Crohn's disease (CD) progresses to structural bowel damage (SBD). The Lémann Index (LI) captures stricture extent/severity, penetrating disease and surgery as a SBD score, and is earmarked for future CD modification trials. Understanding knowledge gaps and perceived barriers is critical to wider adoption. METHODS: A multinational, cross-sectional study was distributed through a survey link (REDCap, Research Electronic Data Capture) to gastrointestinal professional societies with snowball sampling using 23 questionnaire items in 5 sections to determine SBD and LI knowledge, and LI acceptability. Factors associated with acceptability and perception were evaluated. RESULTS: Of the 107 respondents, 49 (45.8%) were female; 87 (81.3%) were from Europe. Most were inflammatory bowel disease specialists (n = 80, 74.8%) or general gastroenterologists (n = 22, 20.6%), managing > 40 CD patients per month (n = 35, 32.7%). A total of 98 (91.6%) knew about SBD; "very important" rating for clinical trials and clinical practice was 56.1% and 41.4%, respectively. A 39.3% describe LI scoring as "very difficult" or "difficult"; 33.6% reported "significant" or "a lot" of effort. Acceptability (composite scores of > 36) were significantly associated with respondents who had received LI training (P<0.001). Automated methods, intestinal ultrasound and evidence of benefit would encourage LI use in clinical trials, while additional time and automated methods would promote use in clinical practice. The top 3 perceived adoption barriers were: lack of time (60.7%), limited automated methods (47.7%) and need for dedicated radiologists (38.3%). CONCLUSIONS: Most respondents had baseline knowledge of SBD. The LI was perceived as important for advancing future CD research and care. More training and automation will facilitate LI adoption.
Source: Intestinal Research
Institutions: St Mark's Hospital, Imperial College London, University of Copenhagen, Amager Hospital, Hvidovre Hospital, Copenhagen University Hospital, Icahn School of Medicine at Mount Sinai, Inserm, Université Clermont Auvergne, Centre Hospitalier Universitaire de Clermont-Ferrand, Hôpital Saint-Louis, University of Lisbon, Hospital da Luz, Hospital Beatriz Ângelo
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: diamond
Award: G1268334072
OpenAlex ID: W4415642601
